Director's Dealing • Mar 9, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 4396S
Spire Healthcare Group PLC
09 March 2023
9 March 2023
Spire Healthcare Group plc (the "Company" or "Spire Healthcare")
Acquisition of Spire Healthcare shares by a Spire Healthcare Director
The following Spire Healthcare Director has purchased ordinary shares in the Company as follows:
| Director | Position | Shares purchased | Date of purchase | Price | Holding post announcement |
| Justin Ash | Chief Executive Officer | 11,062 | 8 March 2023 | 226.0 pence | 430,024 |
Enquiries:
Philip Davies
Company Secretary
07803 508348
Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Executive Officer and Executive Director | |
| b) | Initial notification /Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each GB00BNLPYF73 |
|
| b) | Nature of the transaction | Purchase of 11,062 ordinary shares at 226.0 pence each | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 226.0 pence | 11,062 | ||
| d) | Aggregated information - Aggregated volume - Price |
As above | |
| e) | Date of the transaction | 2023-03-08 | |
| f) | Place of the transaction | XLON |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGCGDXRBGDGXC
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.